Encompass Health Corp (EHC) stock

EHCNYSEServices-HospitalsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 16/3013% above fair value

$140.83−1.41 (-0.99%)

Close on Nov 12, 2026Market cap $13.89BP/E 22.9Yield 0.51%

Encompass Health r&d expenses

Research and development expenses are spending on new products and technology.

Encompass Health has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in Encompass Health's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-5 reverse split on Oct 26, 2006
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is EHC.

Revenue growth9.5% · median 8.0%

Net margin10.0% · median 4.8%

Advertisement
300 × 250

See a number that looks wrong?